Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.

Hot Products

InnoCare Announces Dosing of First Patient in Clinical Study of the Combination of SHP2 Inhibitor ICP-189 and EGFR Inhibitor Furmonertinib

PharmaSourcesApril 01, 2024

Tag: ICP-189 , SHP2 inhibitor , InnoCare

PharmaSources Customer Service